Central Pennsylvania Eye Center, Hershey
Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio
JAMA Ophthalmol. 2017 Dec 1;135(12):1401-1409. doi: 10.1001/jamaophthalmol.2017.4989.
Demonstrating that success of Descemet stripping automated endothelial keratoplasty is similar across donor cornea preservation times (PTs) could increase the donor pool.
To determine whether the 3-year rate of graft success using corneal donor tissue preserved 8 to 14 days is noninferior to that of donor tissue preserved 7 days or less.
DESIGN, SETTING, AND PARTICIPANTS: A multicenter, double-masked, randomized noninferiority clinical trial was conducted from April 16, 2012, to June 5, 2017, at 40 clinical sites (70 surgeons) in the United States, with donor corneas provided by 23 US eye banks. A total of 1090 individuals (1330 study eyes) underwent Descemet stripping automated endothelial keratoplasty (1255 eyes [94.4%] for Fuchs endothelial corneal dystrophy).
Descemet stripping automated endothelial keratoplasty with random assignment of a donor cornea with a PT of 7 days or less (0-7d PT) or 8 to 14 days (8-14d PT).
Graft success at 3 years.
Of the 1090 participants (1330 study eyes; 60.2% women and 39.8% men; median age at enrollment, 70 years [range, 42-90 years]), the 3-year cumulative probability of graft success was 95.3% (95% CI, 93.6%-96.9%) in the 0-7d PT group and 92.1% (95% CI, 89.9%-94.2%) in the 8-14d PT group (difference, 3.2%). The upper limit of the 1-sided 95% CI on the difference was 5.4%, exceeding the prespecified noninferiority limit of 4%. The difference was mostly owing to more primary donor failures in the 8-14d PT group, with the conditional probability of failure after the first month being 2.4% in the 0-7d PT group and 3.1% in the 8-14d PT group. In preplanned secondary analyses, longer PT was associated with a lower rate of graft success (unadjusted hazard ratio for graft failure per additional day of PT, 1.10; 95% CI, 1.03-1.18; P = .008 [PT analyzed as days]), with success rates of 96.5% (95% CI, 92.3%-98.4%) for PT of 4 days or less, 94.9% (95% CI, 92.5%-96.6%) for PT of 5 to 7 days, 93.8% (95% CI, 91.0%-95.8%) for PT of 8 to 11 days, and 89.3% (95% CI, 84.4%-92.7%) for PT of 12 to 14 days (P = .01 [PT analyzed as categorical variable]).
The 3-year success rate in eyes undergoing Descemet stripping automated endothelial keratoplasty was high irrespective of PT. However, the study was unable to conclude that the success rate with donor corneas preserved 8 to 14 days was similar to that of corneas preserved 7 days or less with respect to the prespecified noninferiority limit. Although longer PT was associated with a lower success rate, the difference in rates was small when PT was less than 12 days.
证明 Descemet 剥离自动内皮角膜移植术的成功率在供体角膜保存时间(PT)相似可以增加供体库。
确定使用保存 8 至 14 天的供体组织进行角膜移植的 3 年成功率是否不亚于保存 7 天或更短时间的供体组织。
设计、地点和参与者:一项多中心、双盲、随机非劣效性临床试验于 2012 年 4 月 16 日至 2017 年 6 月 5 日在 40 个临床地点(70 名外科医生)进行,在美国由 23 个美国眼库提供供体角膜。共有 1090 人(1330 只研究眼)接受了 Descemet 剥离自动内皮角膜移植术(1255 只眼[94.4%]用于 Fuchs 内皮角膜营养不良)。
随机分配供体角膜的 Descemet 剥离自动内皮角膜移植术,供体角膜的 PT 为 7 天或更短(0-7d PT)或 8 至 14 天(8-14d PT)。
3 年的移植物成功率。
在 1090 名参与者(1330 只研究眼;60.2%为女性,39.8%为男性;入组时的中位年龄为 70 岁[范围,42-90 岁])中,0-7d PT 组的 3 年累积移植物成功率为 95.3%(95%CI,93.6%-96.9%),8-14d PT 组为 92.1%(95%CI,89.9%-94.2%)(差异为 3.2%)。差异的单侧 95%CI 上限为 5.4%,超过了预设的非劣效性限值 4%。差异主要是由于 8-14d PT 组中更多的原发性供体失败,0-7d PT 组中第一个月后失败的条件概率为 2.4%,8-14d PT 组为 3.1%。在预先计划的次要分析中,PT 较长与移植物成功率较低相关(PT 每增加一天,移植物失败的调整风险比为 1.10;95%CI,1.03-1.18;P=0.008[PT 作为天数分析]),PT 为 4 天或更短时成功率为 96.5%(95%CI,92.3%-98.4%),PT 为 5 至 7 天为 94.9%(95%CI,92.5%-96.6%),PT 为 8 至 11 天为 93.8%(95%CI,91.0%-95.8%),PT 为 12 至 14 天为 89.3%(95%CI,84.4%-92.7%)(P=0.01[PT 作为分类变量分析])。
无论 PT 如何,接受 Descemet 剥离自动内皮角膜移植术的眼的 3 年成功率都很高。然而,该研究无法得出结论,即与保存 7 天或更短时间的供体角膜相比,保存 8 至 14 天的供体角膜的成功率相似,达到了预定的非劣效性限值。尽管 PT 较长与成功率较低相关,但当 PT 小于 12 天时,差异很小。